Management of nondiagnostic thyroid fine needle aspiration cytology nodules based on TI-RADS risk assessment
European Thyroid Journal · 2026
DOI: 10.1530/etj-26-0237 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Thyroid Journal, 2026. Verfasst von Reettika Chanda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Cumming School of Medicine, University of Calgary , Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Thyroid Nodule, Thyroid Neoplasms, Thyroid Gland. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The high prevalence of thyroid nodules and the frequent occurrence of nondiagnostic (ND) results on fine-needle aspiration (FNA) necessitate malignancy risk stratification to balance cancer detection while avoiding unnecessary repeat biopsies. This study evaluated malignancy rates and management strategies for nodules with ND cytology, stratified by the American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) score.
Methods
This retrospective study analyzed 342 consecutive patients with initial ND ultrasound-guided (USG) thyroid FNA at a high-volume, two-practitioner clinic between January 2019 and June 2024. Data collected from chart reviews included Bethesda cytopathology classifications, management approaches, and final histopathological diagnoses when available.
Results
Among 3,717 thyroid FNAs performed during the study period, 342 (9.2%) were ND on initial sampling. The TI-RADS (TR) distribution for ND nodules was as follows: TR1 9.6%, TR2 9.9%, TR3 28.1%, TR4 45.3%, and TR5 7.0%. Initial management comprised repeat FNA in 170 (49.7%) patients, ultrasound (US) surveillance in 101 (29.5%), and surgery in 17 (5.0%); 54 (15.8%) patients were lost to follow-up. Of the repeat FNAs, 47 (27.6%) remained ND. Of the 33 surgical cases, malignancy was identified in six (1.8%) index nodules with initial ND cytology. Five malignancies occurred in TR4 nodules and one in a TR5 nodule. Importantly, no malignancies were identified among the 17 resected TR1–3 nodules.
Conclusion
For experienced practitioners in a high-volume clinic, ND thyroid FNA cytology carries a low overall observed risk of malignancy (1.8%). TI-RADS scores should be taken into consideration to guide management decisions for ND cytology nodules between repeat FNA, US surveillance, or surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Cumming School of Medicine, University of Calgary , Calgary, Alberta, Canada.
- Division of Endocrinology & Metabolism, Department of Medicine, University of Calgary , Calgary, Alberta, Canada.
- Department of Pathology and Laboratory Medicine, Alberta Precision Laboratories, Cumming School of Medicine, University of Calgary , Calgary, Alberta, Canada.
ORCID-Profile: Reettika Chanda, James N Scott
Zitieren
APA
Chanda, R., Ghaznavi, S., Lysack, J. T., Khalil, M., Neuburger, L., & Scott, J. N. (2026). Management of nondiagnostic thyroid fine needle aspiration cytology nodules based on TI-RADS risk assessment. European Thyroid Journal. https://doi.org/10.1530/etj-26-0237
Vancouver
Chanda R, Ghaznavi S, Lysack JT, Khalil M, Neuburger L, Scott JN. Management of nondiagnostic thyroid fine needle aspiration cytology nodules based on TI-RADS risk assessment. European Thyroid Journal. 2026. doi:10.1530/etj-26-0237
BibTeX
@article{Chanda2026,
author = {Chanda, Reettika and Ghaznavi, Sana and Lysack, John Timothy and Khalil, Moosa and Neuburger, Laura and Scott, James N},
title = {Management of nondiagnostic thyroid fine needle aspiration cytology nodules based on TI-RADS risk assessment},
journal = {European Thyroid Journal},
year = {2026},
doi = {10.1530/etj-26-0237}
}
EUVIMED